Skip to main content
THERAGEN ETEX CO.,LTD. logo

THERAGEN ETEX CO.,LTD. — Investor Relations & Filings

Ticker · 066700 ISIN · KR7066700006 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2021-07-26 Capital/Financing Update
Country KR South Korea
Listing KO 066700

About THERAGEN ETEX CO.,LTD.

http://www.theragenetex.com/

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (TerraGen Etex) regarding the 'Acquisition of Bonds before Maturity' (specifically Convertible Bonds). It details the bond series, acquisition amount, reason (Put Option exercise), and method (OTC purchase). This type of disclosure regarding capital structure changes and debt management falls under the 'Capital/Financing Update' category.
2021-07-26 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Theragen Etex' (주)테라젠이텍스, covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial and corporate information, including company overview, capital changes, shareholding status, and dividend information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder changes their stake in a company. This falls under the category of Director's Dealing (DIRS), as it reports the share ownership status and changes for an executive (Lee Jeong-geun) of the company Teragen Etex.
2021-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of agenda items such as financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-03-31 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an 'Annual Report' (사업보고서) filed by Theragen Etex. It contains detailed financial tables, shareholder information, and management disclosures, which are characteristic of a full annual filing. Although it is a correction, it functions as the primary annual financial disclosure document for the company for the fiscal year 2020. FY 2020
2021-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This is a standard corporate governance disclosure required by the Financial Services Commission/Korea Exchange regarding changes in the board of directors. Since it specifically details the appointment of an outside director, it falls under the category of Board/Management Information (MANG).
2021-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.